[{"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204637"], "brand_name": ["AZELAIC ACID"], "generic_name": ["AZELAIC ACID"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-626"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["AZELAIC ACID"], "rxcui": ["1041518"], "spl_id": ["28cca0c1-2f38-4fa2-8aaf-d3c8978b0fc6"], "spl_set_id": ["0b5ab22e-c78a-4429-9a76-a4ba2d11fcde"], "package_ndc": ["68462-626-52"], "is_original_packager": [true], "upc": ["0368462626528"], "nui": ["N0000008841", "N0000009982"], "pharm_class_pe": ["Decreased Protein Synthesis [PE]", "Decreased Sebaceous Gland Activity [PE]"], "unii": ["F2VW3D43YT"]}, "product_type": "Drugs", "event_id": "97619", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0662-2025", "product_description": "Azelaic Acid Gel, 15%, 50 grams, For Topical Use Only, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52", "product_quantity": "13824 tubes", "reason_for_recall": "CGMP Deviations: Market complaints received for gritty texture (grainy)", "recall_initiation_date": "20250917", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Batch # 19252524, Exp Date: May 2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0668-2025", "product_description": "edunn clarity, BP Treatment Cleanser 10% (Benzoyl Peroxide 10%), 7 oz (201g) Uptown Medi Spa, Phoenix, AZ.", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209288"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-511", "67877-512", "67877-513", "67877-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["777b866a-796a-4d15-8cb6-dd0c9a1856e2"], "spl_set_id": ["67e60880-091a-4df7-8696-6e6c42a490e2"], "package_ndc": ["67877-511-90", "67877-511-05", "67877-511-10", "67877-511-55", "67877-511-33", "67877-511-38", "67877-512-90", "67877-512-05", "67877-512-10", "67877-512-44", "67877-512-33", "67877-512-38", "67877-513-90", "67877-513-05", "67877-513-10", "67877-513-23", "67877-513-33", "67877-513-38", "67877-514-90", "67877-514-05", "67877-514-10", "67877-514-33", "67877-514-38"], "is_original_packager": [true], "upc": ["0367877512051", "0367877513102", "0367877514109"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "97639", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0020-2026", "product_description": "Atorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDC 67877-514-05), Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054", "product_quantity": "", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250919", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot#: 25140249, Exp. Dec. 2026 Lot#: 25140247, Exp. Dec. 2026 Lot#: 24144999, Exp. Nov. 2026 Lot#: 24144942, Exp. Nov. 2026 Lot#: 24144845, Exp. Nov. 2026 Lot#: 24144713, Exp. Nov. 2026 Lot#: 24144652, Exp. Oct. 2026 Lot#: 24143898, Exp. Aug. 2026 Lot#: 24143412, Exp. Aug. 2026 Lot#: 24143582, Exp. Aug. 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206745"], "brand_name": ["ENTECAVIR"], "generic_name": ["ENTECAVIR"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-920", "68382-921"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ENTECAVIR"], "rxcui": ["485434", "485436"], "spl_id": ["b9646f09-8d5b-4271-b2b1-b1d66a91ed73"], "spl_set_id": ["b4fd0e22-ad23-4f51-9b98-95182f63c2eb"], "package_ndc": ["68382-920-06", "68382-920-16", "68382-920-01", "68382-920-30", "68382-920-77", "68382-921-06", "68382-921-16", "68382-921-01", "68382-921-30", "68382-921-77"], "is_original_packager": [true], "unii": ["5968Y6H45M"]}, "product_type": "Drugs", "event_id": "97684", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0001-2026", "product_description": "Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.", "product_quantity": "912 30-count bottles", "reason_for_recall": "Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity", "recall_initiation_date": "20250924", "center_classification_date": "20251002", "report_date": "20251008", "code_info": "Lot#: E409308, Exp 12/31/2026"}, {"status": "Ongoing", "city": "Hyderabad", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA211020"], "brand_name": ["BUPROPION HYDROCHLORIDE"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-862", "16571-863"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993541", "993557"], "spl_id": ["a047dcfb-9b8c-446e-815e-2ee800cc7b79"], "spl_set_id": ["e4f4d3fa-ddf6-4125-8486-8157efc095c1"], "package_ndc": ["16571-862-03", "16571-862-09", "16571-862-50", "16571-862-10", "16571-862-12", "16571-863-03", "16571-863-09", "16571-863-50", "16571-863-10"], "is_original_packager": [true], "upc": ["0316571862030", "0316571863037"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "97629", "recalling_firm": "Graviti Pharmaceuticals Private Limited", "address_1": "E & 621 Patancheru Mandal", "address_2": "Isnapur Village Rd; Survey No 621", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.", "recall_number": "D-0037-2026", "product_description": "Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.", "product_quantity": "46,512/30 count bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications", "recall_initiation_date": "20250915", "center_classification_date": "20251021", "report_date": "20251029", "code_info": "Batch # BPB124341A, Exp date: 10/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M003"], "brand_name": ["70% ISOPROPYL RUBBING ALCOHOL"], "generic_name": ["ISOPROPYL RUBBING ALCOHOL"], "manufacturer_name": ["TOPCO ASSOCIATES LLC"], "product_ndc": ["36800-589"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["808520"], "spl_id": ["374cac07-0520-1ce9-e063-6294a90a6d2b"], "spl_set_id": ["9fbded5f-8dc1-4134-a711-48d1a581d874"], "package_ndc": ["36800-589-14", "36800-589-72", "36800-589-43", "36800-589-45"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "97506", "recalling_firm": "Consumer Product Partners, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0661-2025", "product_description": "TopCare Health 70% Isopropyl Alcohol, NET WT 5.5 OZ (156 g) per can, Distributed By The KROGER CO., Cincinnati, Ohio 45202.  NDC:  36800-589-14", "product_quantity": "60 bottles", "reason_for_recall": "Cross Contamination with Other Products.", "recall_initiation_date": "20250825", "center_classification_date": "20250923", "report_date": "20251001", "code_info": "Lot 0662036; Exp Date 06/19/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M003"], "brand_name": ["70% ISOPROPYL RUBBING ALCOHOL"], "generic_name": ["ISOPROPYL RUBBING ALCOHOL"], "manufacturer_name": ["Kroger CO"], "product_ndc": ["30142-810"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["808520"], "spl_id": ["36bf5591-e5eb-4038-e063-6394a90ac03c"], "spl_set_id": ["b127bba1-ce0b-4142-8b7d-f12f062b0938"], "package_ndc": ["30142-810-72", "30142-810-43", "30142-810-45", "30142-810-14"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "97506", "recalling_firm": "Consumer Product Partners, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0660-2025", "product_description": "Kroger 70% Isopropyl Alcohol, NET WT 5.5 OZ (156 g) per can, Distributed By The KROGER CO., Cincinnati, Ohio 45202.  NDC:  30142-810-14", "product_quantity": "1860 bottles", "reason_for_recall": "Cross Contamination with Other Products.", "recall_initiation_date": "20250825", "center_classification_date": "20250923", "report_date": "20251001", "code_info": "Lot 0662036; Exp. Date  06/19/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Seymour", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203899"], "brand_name": ["NIACIN"], "generic_name": ["NIACIN"], "manufacturer_name": ["Lannett Company, Inc."], "product_ndc": ["62175-320", "62175-322"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NIACIN"], "rxcui": ["1098134", "1098141"], "spl_id": ["cd76800b-78a7-47ad-9ffa-4088e7984104"], "spl_set_id": ["d7b66e13-00ed-48a9-a54a-8e474cc31d54"], "package_ndc": ["62175-320-46", "62175-320-43", "62175-322-46", "62175-322-43"], "is_original_packager": [true], "upc": ["0362175320469", "0362175322463"], "nui": ["N0000175594", "M0014839"], "pharm_class_epc": ["Nicotinic Acid [EPC]"], "pharm_class_cs": ["Nicotinic Acids [CS]"], "unii": ["2679MF687A"]}, "product_type": "Drugs", "event_id": "97778", "recalling_firm": "Lannett Company Inc.", "address_1": "1101 C Ave W", "address_2": "", "postal_code": "47274-3342", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0096-2026", "product_description": "Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136.  NDC:  62175-322-46", "product_quantity": "46,848 90-count bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20251010", "center_classification_date": "20251022", "report_date": "20251029", "code_info": "Lot, expiry: 21264027A, Exp 10/30/2025; 22266446A, Exp 12/31/2025; 22266901A, Exp 02/28/2026; 22267553A, 22267554A,  Exp 03/31/2026; 22267555A, Exp 02/28/2026; 22267992A, Exp 04/30/2026; 22267993A, 22267994A, Exp 05/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091442"], "brand_name": ["BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION"], "generic_name": ["BRIMONIDINE TARTRATE AND TIMOLOL MALEATE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0589"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["BRIMONIDINE TARTRATE", "TIMOLOL MALEATE"], "rxcui": ["861635"], "spl_id": ["1b350584-a1be-e9a4-9c25-00ec1a8ee4b7"], "spl_set_id": ["268c3f6b-8798-7987-3b8c-7b7f560af5d7"], "package_ndc": ["60505-0589-1", "60505-0589-2", "60505-0589-3", "0036050505", "6050505892"], "is_original_packager": [true], "unii": ["4S9CL2DY2H", "P8Y54F701R"]}, "product_type": "Drugs", "event_id": "97561", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0676-2025", "product_description": "Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1 (5 mL), NDC 60505-0589-2 (10 mL).", "product_quantity": "151,034 bottles", "reason_for_recall": "Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns", "recall_initiation_date": "20250905", "center_classification_date": "20250930", "report_date": "20251008", "code_info": "a) lot # VE0614 exp. date 12/2025 UPC:(01)00360505058914 (5 mL)  b) lot # VE0616 exp. date 12/2025 UPC:(01)0(03)60505058921 (10 mL)"}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0663-2025", "product_description": "ARTISAN OF SKIN (Benzoyl Peroxide 10%) , 7 oz (201 g), Artisan of Skin Beverly Hills, CA 90210", "product_quantity": "125", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090858"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Major Pharmaceuticals", "Cardinal Health 107, LLC"], "product_ndc": ["0904-6665", "0904-6666", "0904-6667", "55154-3363", "55154-7992", "55154-7993"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310430", "310431", "310432"], "spl_id": ["b6880b32-3ebc-4b0e-8a84-d513f3e401af", "c5f4a9a6-33bb-4e3a-a8ac-ca41e8355b40"], "spl_set_id": ["36f74fdf-0dae-47a0-a7ea-e64ac91cd88f", "41844c21-9e2a-4332-a8ff-9b71ae9032b0"], "package_ndc": ["0904-6665-61", "0904-6666-61", "0904-6667-61", "55154-3363-0", "55154-7992-0", "55154-7993-0"], "original_packager_product_ndc": ["67877-222", "67877-223", "67877-224", "0904-6665", "0904-6666", "0904-6667"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"], "upc": ["0055154799300", "0055154799201", "0055154336307"]}, "product_type": "Drugs", "event_id": "97777", "recalling_firm": "The Harvard Drug Group LLC", "address_1": "7000 Cardinal Pl", "address_2": "", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "US Nationwide.", "recall_number": "D-0031-2026", "product_description": "Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61 (Blister pack), NDC 55154-3363-0 (Outer Bag).", "product_quantity": "", "reason_for_recall": "Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .", "recall_initiation_date": "20251010", "center_classification_date": "20251017", "report_date": "20251029", "code_info": "Lot # M04989A [Bag], M04989 [Blister Pack], Exp Date: 02/2026; Lot # M05056A [Bag], M05056 [Blister Pack], Exp Date: 04/2026; Lot # M05150A [Bag], M05150 [Blister Pack], Exp Date: 07/2026; Lot # M05312A [Bag], M05312 [Blister Pack], and M05342A [Bag], M05342 [Blister Pack], Exp Date: 01/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0672-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 20 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-032-01", "product_quantity": "11,909 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot#: GPC250179A, Exp Date:  06-22-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091232"], "brand_name": ["NORGESTIMATE AND ETHINYL ESTRADIOL"], "generic_name": ["NORGESTIMATE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["AvKARE"], "product_ndc": ["42291-565"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["578732", "748797", "749155", "749156", "749157"], "spl_id": ["0e9925c8-d7f8-5cea-e063-6294a90a50a2"], "spl_set_id": ["a3ce752d-58df-363d-e053-2a95a90a5411"], "package_ndc": ["42291-565-28", "42291-565-84"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "97542", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0007-2026", "product_description": "Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only,  Manufactured for AvKARE, Pulaski, TN 38478.  Carton NDC:  42291-565-84; Blister NDC:  42291-565-28", "product_quantity": "2192 cartons", "reason_for_recall": "Failed Content Uniformity Specifications", "recall_initiation_date": "20250902", "center_classification_date": "20251006", "report_date": "20251015", "code_info": "Lot # LF41138A; Exp 06/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213212"], "brand_name": ["CARBIDOPA, LEVODOPA AND ENTACAPONE"], "generic_name": ["CARBIDOPA, LEVODOPA AND ENTACAPONE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-689", "16571-690", "16571-691", "16571-692", "16571-693", "16571-694"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARBIDOPA", "ENTACAPONE", "LEVODOPA"], "rxcui": ["403850", "403851", "403852", "730988", "810083", "810090"], "spl_id": ["bb341ca1-04d3-4a71-b79d-824653aa58a3"], "spl_set_id": ["2f8e82d7-6baf-456a-b8c3-4fda6e317902"], "package_ndc": ["16571-689-01", "16571-690-01", "16571-691-01", "16571-692-01", "16571-693-01", "16571-694-01"], "is_original_packager": [true], "upc": ["0316571689019", "0316571692019", "0316571694013", "0316571690015", "0316571691012", "0316571693016"], "nui": ["N0000175754", "N0000175755", "N0000175756", "N0000175757", "N0000193220", "M0370111"], "pharm_class_epc": ["Aromatic Amino Acid Decarboxylation Inhibitor [EPC]", "Catechol-O-Methyltransferase Inhibitor [EPC]", "Aromatic Amino Acid [EPC]"], "pharm_class_moa": ["DOPA Decarboxylase Inhibitors [MoA]", "Catechol O-Methyltransferase Inhibitors [MoA]"], "pharm_class_cs": ["Amino Acids, Aromatic [CS]"], "unii": ["MNX7R8C5VO", "4975G9NM6T", "46627O600J"]}, "product_type": "Drugs", "event_id": "97768", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0029-2026", "product_description": "Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01", "product_quantity": "2,064 100-count bottles", "reason_for_recall": "Product mix up:  complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).", "recall_initiation_date": "20251007", "center_classification_date": "20251016", "report_date": "20251022", "code_info": "Lot # CS25070, exp. date 03/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mumbai", "state": "", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA077829"], "brand_name": ["CETIRIZINE HYDROCHLORIDE"], "generic_name": ["CETIRIZINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-402"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CETIRIZINE HYDROCHLORIDE"], "rxcui": ["1014678"], "spl_id": ["76ebe5e7-afda-45c3-bf06-07e37827a07a"], "spl_set_id": ["5481ccb3-b311-4b25-b923-4fe8522ea92b"], "package_ndc": ["16571-402-10", "16571-402-50"], "is_original_packager": [true], "unii": ["64O047KTOA"]}, "product_type": "Drugs", "event_id": "97573", "recalling_firm": "JB Chemicals and Pharmaceuticals Ltd", "address_1": "Neelam Centre A Wing A B Wing", "address_2": "4th Floor; Hind Cycle Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0032-2026", "product_description": "Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10.", "product_quantity": "9936 bottles", "reason_for_recall": "Tablet/Capsules Imprinted with Wrong ID", "recall_initiation_date": "20250912", "center_classification_date": "20251017", "report_date": "20251029", "code_info": "Lot # PY925014A; Exp. 1/31/2028", "more_code_info": ""}, {"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212294"], "brand_name": ["TAVABOROLE"], "generic_name": ["TAVABOROLE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-102"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["TAVABOROLE"], "rxcui": ["1543177"], "spl_id": ["266f7bbc-b540-4681-8144-cbb823f34f0e"], "spl_set_id": ["c13610c8-c57a-4519-b37d-eb4fbdcec398"], "package_ndc": ["72578-102-04"], "is_original_packager": [true], "nui": ["N0000191279", "N0000000150", "M0002832"], "pharm_class_epc": ["Oxaborole Antifungal [EPC]"], "pharm_class_moa": ["Protein Synthesis Inhibitors [MoA]"], "pharm_class_cs": ["Boron Compounds [CS]"], "unii": ["K124A4EUQ3"]}, "product_type": "Drugs", "event_id": "97756", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0016-2026", "product_description": "Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar, Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-102-04.", "product_quantity": "13080 bottles", "reason_for_recall": "Discoloration - Expansion of RES #97424", "recall_initiation_date": "20251006", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot#: T400819, T400820, Exp 4/30/26; T401969, Exp 9/30/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0670-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-030-01", "product_quantity": "11,895 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "lot#: GPC250159A, Exp Date: 06-22-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97779", "recalling_firm": "STAQ Pharma, Inc.", "address_1": "14135 E 42nd Ave Ste 50", "address_2": "", "postal_code": "80239-5214", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0024-2026", "product_description": "Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.", "product_quantity": "", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20251009", "center_classification_date": "20251015", "report_date": "20251022", "code_info": "Lot #: 25156673A, Expiry: 02FEB2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209288"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-511", "67877-512", "67877-513", "67877-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["777b866a-796a-4d15-8cb6-dd0c9a1856e2"], "spl_set_id": ["67e60880-091a-4df7-8696-6e6c42a490e2"], "package_ndc": ["67877-511-90", "67877-511-05", "67877-511-10", "67877-511-55", "67877-511-33", "67877-511-38", "67877-512-90", "67877-512-05", "67877-512-10", "67877-512-44", "67877-512-33", "67877-512-38", "67877-513-90", "67877-513-05", "67877-513-10", "67877-513-23", "67877-513-33", "67877-513-38", "67877-514-90", "67877-514-05", "67877-514-10", "67877-514-33", "67877-514-38"], "is_original_packager": [true], "upc": ["0367877512051", "0367877513102", "0367877514109"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "97639", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0019-2026", "product_description": "Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90),  b). 500-count (NDC 67877-512-05), c). 1000-count(NDC 67877-512-10),Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.", "product_quantity": "", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250919", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot #: 25140150, Exp.  Dec. 2026 Lot #: 25140173, Exp. Dec. 2026 Lot #: 25140172, Exp. Dec. 2026 Lot #: 24144720, Exp. Nov. 2026 Lot #: 24144798, Exp.  Nov. 2026 Lot #: 24144692, Exp. Oct. 2026 Lot #: 24143755, Exp.  Aug. 2026 Lot #: 24143913, Exp. Aug. 2026 Lot #: 24143754, Exp.  Aug. 2026 Lot #: 24143047, Exp. June 2026 Lot #: 24142936, Exp. July 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Elkins Park", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97831", "recalling_firm": "ibspot", "address_1": "1414 Willow Ave", "address_2": "", "postal_code": "19027-3147", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "WY and VA", "recall_number": "D-0098-2026", "product_description": "Taoscare Motion Sickness Patches 36-count box, Henan Xinyongtal Medical Technology., Ltd., Address: he nan sheng zhou kou shi huai yang xian gong ye yuan qu, X003SR097N", "product_quantity": "3 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA", "recall_initiation_date": "20251009", "center_classification_date": "20251023", "report_date": "20251029", "code_info": "none", "more_code_info": ""}, {"status": "Ongoing", "city": "Dabhel, Daman", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97766", "recalling_firm": "USV Private Limited", "address_1": "H-13, 16, 16a, 17, 18, 19, 20, 21 & E-22, Oidc, Mahatma Gandhi Udyog Nagar", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0034-2026", "product_description": "Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05", "product_quantity": "8,952 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.", "recall_initiation_date": "20251009", "center_classification_date": "20251020", "report_date": "20251029", "code_info": "Lot #:  35000409, Exp. Date 01/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0013-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7133-61, UPC (01)00309047133611  NDC 0904-7133-61", "product_quantity": "1394 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N01928, Exp. Date, 09/30/2025, N02008, Exp. Date, 03/21/2026 & N02071, Exp. Date 02/28/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"], "upc": ["003090471316"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0011-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 Tablets, (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7131-61, UPC (01)00309047131617", "product_quantity": "506 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N02009 & N02026, exp. date 02/28/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0010-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7130-61, UPC (01)00309047130610", "product_quantity": "1256 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N01954, Exp. Date, 11/30/2025 & N02024, Exp. Date, 02/28/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206745"], "brand_name": ["ENTECAVIR"], "generic_name": ["ENTECAVIR"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-920", "68382-921"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ENTECAVIR"], "rxcui": ["485434", "485436"], "spl_id": ["b9646f09-8d5b-4271-b2b1-b1d66a91ed73"], "spl_set_id": ["b4fd0e22-ad23-4f51-9b98-95182f63c2eb"], "package_ndc": ["68382-920-06", "68382-920-16", "68382-920-01", "68382-920-30", "68382-920-77", "68382-921-06", "68382-921-16", "68382-921-01", "68382-921-30", "68382-921-77"], "is_original_packager": [true], "unii": ["5968Y6H45M"]}, "product_type": "Drugs", "event_id": "97684", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0002-2026", "product_description": "Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.", "product_quantity": "600 30-count bottles", "reason_for_recall": "Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity", "recall_initiation_date": "20250924", "center_classification_date": "20251002", "report_date": "20251008", "code_info": "Lot#: E409309, Exp 12/31/2026"}, {"status": "Ongoing", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210664"], "brand_name": ["DOXYCYCLINE"], "generic_name": ["DOXYCYCLINE HYCLATE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE HYCLATE"], "rxcui": ["1650143"], "spl_id": ["3b12eb84-4431-551b-e063-6294a90acd6c"], "spl_set_id": ["3fb9f5ad-90a2-4858-bc34-f800d8b2fa90"], "package_ndc": ["42192-501-50", "42192-501-05"], "is_original_packager": [true], "upc": ["0342192501058"], "unii": ["19XTS3T51U"]}, "product_type": "Drugs", "event_id": "97716", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110", "address_2": "", "postal_code": "30005-1795", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0014-2026", "product_description": "Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.", "product_quantity": "4,680 500-count bottles", "reason_for_recall": "Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.", "recall_initiation_date": "20250929", "center_classification_date": "20251009", "report_date": "20251015", "code_info": "Lot #: P24ZLK1, Exp 5/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074415"], "brand_name": ["SUCRALFATE"], "generic_name": ["SUCRALFATE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-695"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUCRALFATE"], "rxcui": ["314234"], "spl_id": ["37dbc9fb-25b5-30a2-e063-6294a90a78b8"], "spl_set_id": ["e7364686-3638-4061-ae4a-62b1df7af9d0"], "package_ndc": ["60687-695-11", "60687-695-01"], "original_packager_product_ndc": ["29033-003"], "nui": ["N0000175801", "M0015420"], "pharm_class_epc": ["Aluminum Complex [EPC]"], "pharm_class_cs": ["Organometallic Compounds [CS]"], "unii": ["XX73205DH5"]}, "product_type": "Drugs", "event_id": "97794", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0027-2026", "product_description": "Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]", "product_quantity": "27,868 blister packs", "reason_for_recall": "CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.", "recall_initiation_date": "20251009", "center_classification_date": "20251016", "report_date": "20251022", "code_info": "Lot #: 1017392, Exp. Date 01/31/2026; 1017415, Exp. Date 12/31/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Chambersburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97688", "recalling_firm": "Acuity Specialty Products, Inc.", "address_1": "800 Development Ave", "address_2": "", "postal_code": "17201-4103", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0005-2026", "product_description": "AFCO, Hand Sanitizer (Isopropyl Alcohol-Based, Product 5515), Manufactured by: AFCO, 550 Development Avenue, Chambersburg, PA 17201, Toll Free: 800-345-1329, Package Configuration: a) 4x1 Gallon Case, 5 Gallon Pail, 55 Gallon Drum.", "product_quantity": "", "reason_for_recall": "cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.", "recall_initiation_date": "20250929", "center_classification_date": "20251006", "report_date": "20251015", "code_info": "Lot # C2432725, Exp 11/22/2025; Lot # C2508304, Exp 3/24/2026; Lot # C2509304, Exp 4/3/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0009-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 50 Tablets (5x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7130-06, UPC (01)00309047130061", "product_quantity": "2064 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N01943 and Lot N02025, exp. date 02/28/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0666-2025", "product_description": "mel rx Skin, NO DRAMA Benzoyl Peroxide 10% Acne Treatment, 7 oz, 201 g Mel Skin Rx Beverly Hills, CA 90210", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97811", "recalling_firm": "Medline Industries, LP", "address_1": "3 Lakes Dr", "address_2": "", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0035-2026", "product_description": "Medline, Alcohol Prep Pads (2-Ply Pad, 70% Isopropyl Alcohol), 100 eaches per box, 10 boxes per case (1,000 eaches per case), Single Use Only, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL, 60093 USA, NDC 55329-811-30.", "product_quantity": "222,800 eaches", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250929", "center_classification_date": "20251021", "report_date": "20251029", "code_info": "Lot #: 61224040057", "more_code_info": ""}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0669-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-029-01", "product_quantity": "3,384 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot#: GPC250158A, Exp Date: 06-22-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076109"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-1003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["KETOROLAC TROMETHAMINE"], "spl_id": ["fb740a51-5459-3c22-949d-7e4c9142fe84"], "spl_set_id": ["d9a186ba-74a9-b6d4-1109-1e045ba1763e"], "package_ndc": ["60505-1003-1", "60505-1003-2", "6050510031", "3605051003"], "is_original_packager": [true], "unii": ["4EVE5946BQ"], "upc": ["360505100316"]}, "product_type": "Drugs", "event_id": "97561", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0677-2025", "product_description": "Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-1.", "product_quantity": "493,468 bottles", "reason_for_recall": "Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns", "recall_initiation_date": "20250905", "center_classification_date": "20250930", "report_date": "20251008", "code_info": "Batch # VA0444, exp. date 01/2026 Batch # VA4608, exp. date 01/2026 Batch # TZ7016, exp. date 12/2025  UPC on Bottles: (01)0(03)60505100316 UPC on Cartons: 360505100316"}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0671-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01", "product_quantity": "9,917 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot#: GPC250178A, Exp Date: 06-22-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA761070"], "brand_name": ["FASENRA"], "generic_name": ["BENRALIZUMAB"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-1730", "0310-1830", "0310-1745"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["BENRALIZUMAB"], "rxcui": ["1989104", "1989109", "2205632", "2205634", "2679499", "2679502"], "spl_id": ["901977cc-c730-4b8b-9faf-ca24afc3589a"], "spl_set_id": ["da6aca1a-19ed-44a4-abb7-696c7d58b784"], "package_ndc": ["0310-1730-30", "0310-1730-85", "0310-1830-30", "0310-1830-85", "0310-1745-01", "0310-1745-95"], "is_original_packager": [true], "nui": ["N0000193803", "N0000193802"], "pharm_class_epc": ["Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]"], "unii": ["71492GE1FX"]}, "product_type": "Drugs", "event_id": "97760", "recalling_firm": "ASTRAZENECA PHARMACEUTICALS", "address_1": "950 Wind River Ln", "address_2": "", "postal_code": "20878-1974", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0028-2026", "product_description": "Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30", "product_quantity": "916 pre-filled syringes", "reason_for_recall": "Lack of Assurance of Sterility:", "recall_initiation_date": "20251008", "center_classification_date": "20251016", "report_date": "20251022", "code_info": "Lot YJ0152, Expiry: 01/31/2028.", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0012-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7132-61, UPC (01)00309047132614", "product_quantity": "866 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N01920, Exp. Date, 12/31/2025, N02023, Exp. Date, 02/28/2026 & N02202, Exp. Date, 06/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0667-2025", "product_description": "Micronized BPO Gel Cleanser 10% (Benzoyl Peroxide 10%) Pantea MD , 7 oz (201 g), University Skin Institute, 650 University Ave, Ste 200, Sacramento, CA 95825.", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090858"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6665", "0904-6666", "0904-6667"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310430", "310431", "310432"], "spl_id": ["b6880b32-3ebc-4b0e-8a84-d513f3e401af"], "spl_set_id": ["36f74fdf-0dae-47a0-a7ea-e64ac91cd88f"], "package_ndc": ["0904-6665-61", "0904-6666-61", "0904-6667-61"], "original_packager_product_ndc": ["67877-222", "67877-223", "67877-224"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "97777", "recalling_firm": "The Harvard Drug Group LLC", "address_1": "7000 Cardinal Pl", "address_2": "", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "US Nationwide.", "recall_number": "D-0030-2026", "product_description": "Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61", "product_quantity": "", "reason_for_recall": "Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .", "recall_initiation_date": "20251010", "center_classification_date": "20251017", "report_date": "20251029", "code_info": "Lot # M04950, Exp Date: 01/2026; Lot # M04989, M04990, Exp Date: 02/2026; Lot # M05056, Exp Date: 04/2026; Lot # M05150, Exp Date: 07/2026; Lot # M05290, Exp Date: 11/2026; Lot # M05312, M05342, Exp Date: 01/2027; Lot # M05369, M05386, Exp Date: 02/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Chambersburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97688", "recalling_firm": "Acuity Specialty Products, Inc.", "address_1": "800 Development Ave", "address_2": "", "postal_code": "17201-4103", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0004-2026", "product_description": "Wyandotte, Sanifect E3, Hand Sanitizer (Ethanol-Based, Product 5511), Ethyl Alcohol 60.1%, Manufacture By: AFCO, 550 Development Avenue, Chambersburg, PA 17210, Toll Free: 800-345-1329, Package Configurations: a) 6x1000mL Case, b) 4x1 Gallon Case, c) 5 Gallon Pail, d) 55 Gallon Drum.", "product_quantity": "", "reason_for_recall": "cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.", "recall_initiation_date": "20250929", "center_classification_date": "20251006", "report_date": "20251015", "code_info": "Lot # C2427010, Exp 9/26/2025; Lot # C2432621, Exp 11/21/2025; Lot # C2501514, Exp 1/15/2026; Lot # C2508606, Exp 3/27/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["POVIDONE-IODINE"], "generic_name": ["POVIDONE-IODINE"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-939"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["POVIDONE-IODINE"], "rxcui": ["312564"], "spl_id": ["129c8b5c-88ca-c276-e063-6294a90a993f"], "spl_set_id": ["c9036a83-22f5-4a09-b01c-7093d4192c19"], "package_ndc": ["53329-939-04", "53329-939-06", "53329-939-08", "53329-939-23", "53329-939-25", "53329-939-69", "53329-939-13"], "is_original_packager": [true], "nui": ["N0000175486", "M0011640"], "pharm_class_epc": ["Antiseptic [EPC]"], "pharm_class_cs": ["Iodine [CS]"], "unii": ["85H0HZU99M"]}, "product_type": "Drugs", "event_id": "97486", "recalling_firm": "Medline Industries, LP", "address_1": "3 Lakes Dr", "address_2": "N/A", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0674-2025", "product_description": "READYPREP PVP, Povidone-Iodine 10% Solution, Topical Antiseptic, Not Sterile, 1 Gallon (3.78 L) per bottle, Manufactured in USA by Medline Industries, LP., Three Lakes Drive, Northfield, IL 60093, NDC 53329-939-25", "product_quantity": "2,680 bottles", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20250819", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 24EJA180, Exp 06/01/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0664-2025", "product_description": "Skin MD by Dr Monika Kiripolsky, Body Acne Cleanser (Benzoyl Peroxide 10%), 7 oz (201 g),  Monika Kiripolsky, MD Beverly Hills, CA, 90211", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mumbai", "state": "", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA077829"], "brand_name": ["CETIRIZINE HYDROCHLORIDE"], "generic_name": ["CETIRIZINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-402"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CETIRIZINE HYDROCHLORIDE"], "rxcui": ["1014678"], "spl_id": ["76ebe5e7-afda-45c3-bf06-07e37827a07a"], "spl_set_id": ["5481ccb3-b311-4b25-b923-4fe8522ea92b"], "package_ndc": ["16571-402-10", "16571-402-50"], "is_original_packager": [true], "unii": ["64O047KTOA"]}, "product_type": "Drugs", "event_id": "97573", "recalling_firm": "JB Chemicals and Pharmaceuticals Ltd", "address_1": "Neelam Centre A Wing A B Wing", "address_2": "4th Floor; Hind Cycle Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0033-2026", "product_description": "Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50", "product_quantity": "13,440 bottles", "reason_for_recall": "Tablet/Capsules Imprinted with Wrong ID", "recall_initiation_date": "20250912", "center_classification_date": "20251017", "report_date": "20251029", "code_info": "Lot # PY925014, PY925013, Exp. 1/31/2028", "more_code_info": ""}, {"status": "Ongoing", "city": "Ewing", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["ZICAM COLD REMEDY MEDICATED FRUIT DROPS - ELDERBERRY"], "generic_name": ["ZINC ACETATE ANHYDROUS, ZINC GLUCONATE, AND SAMBUCUS NIGRA FLOWERING TOP"], "manufacturer_name": ["Church & Dwight Co., Inc."], "product_ndc": ["10237-469"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["SAMBUCUS NIGRA FLOWERING TOP", "ZINC ACETATE ANHYDROUS", "ZINC GLUCONATE"], "spl_id": ["e2423113-2171-4c6b-83d8-28915ff5e643"], "spl_set_id": ["ce2e9d9b-b49e-ab61-e053-2a95a90a0642"], "package_ndc": ["10237-469-25"], "is_original_packager": [true], "upc": ["0732216301564"], "unii": ["CT03BSA18U", "H2ZEY72PME", "U6WSN5SQ1Z"]}, "product_type": "Drugs", "event_id": "97729", "recalling_firm": "Church & Dwight Co., Inc.", "address_1": "500 Charles Ewing Blvd", "address_2": "", "postal_code": "08628-3448", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0095-2026", "product_description": "ZICAM\" MEDICATED FRUIT DROPS ELDERBERRY FLAVOR, 25-drops per bottle, Distributed by: Church & Dwight Co., Inc. Ewing, NJ 08628, NDC 10237-469-25", "product_quantity": "21,912 bottles", "reason_for_recall": "Labeling: Label Mix-up: The product in the bottle contains elderberry and the label failed to indicate the inclusion of elderberry as an ingredient.", "recall_initiation_date": "20251001", "center_classification_date": "20251022", "report_date": "20251029", "code_info": "Lot#: BE51396303, Exp. Date 2027/05", "more_code_info": ""}, {"status": "Ongoing", "city": "Siddipet (District)", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA217166"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-305", "31722-306", "31722-307"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["23a5daec-e083-eec0-e063-6394a90a2411"], "spl_set_id": ["478aff0b-29fd-43b2-a701-5236b8f8e3df"], "package_ndc": ["31722-305-25", "31722-305-10", "31722-306-25", "31722-307-25", "31722-307-02"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "97711", "recalling_firm": "Aspiro Pharma Limited", "address_1": "Survey No. 321, Biotech Park, Phase Iii", "address_2": "Karkapatla Village, Markook (Mandal)", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0036-2026", "product_description": "Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label).", "product_quantity": "", "reason_for_recall": "Presence of Particulate Matter: Particulate matter identified as glass", "recall_initiation_date": "20251001", "center_classification_date": "20251021", "report_date": "20251029", "code_info": "Lot #: AS1240347A, Exp Date 09/2026; AS1240144A, Exp Date 05/2026; AS1240145A, AS1240146A, Exp Date 06/2026; AS1250295A, Exp Date 05/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "97641", "recalling_firm": "IntegraDose Compounding Services LLC", "address_1": "719 Kasota Ave Se", "address_2": "", "postal_code": "55414-2842", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0015-2026", "product_description": "Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842  NDC 71139-0012-1", "product_quantity": "853/500 mL bags", "reason_for_recall": "Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.", "recall_initiation_date": "20250916", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot #: 20250620OXY-1, Expiration date 10/18/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209288"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-511", "67877-512", "67877-513", "67877-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["777b866a-796a-4d15-8cb6-dd0c9a1856e2"], "spl_set_id": ["67e60880-091a-4df7-8696-6e6c42a490e2"], "package_ndc": ["67877-511-90", "67877-511-05", "67877-511-10", "67877-511-55", "67877-511-33", "67877-511-38", "67877-512-90", "67877-512-05", "67877-512-10", "67877-512-44", "67877-512-33", "67877-512-38", "67877-513-90", "67877-513-05", "67877-513-10", "67877-513-23", "67877-513-33", "67877-513-38", "67877-514-90", "67877-514-05", "67877-514-10", "67877-514-33", "67877-514-38"], "is_original_packager": [true], "upc": ["0367877512051", "0367877513102", "0367877514109"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "97639", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0017-2026", "product_description": "Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottle (NDC 67877-511-05), c). 1000-count bottle (NDC 67877-511-10) Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.", "product_quantity": "141,984 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250919", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot#: 25141249, Exp. Feb. 2027 Lot#: 24144938, Exp. Nov. 2026 Lot#: 24144868, Exp. Nov. 2026 Lot#: 24144867, Exp. Nov. 2026 Lot#: 24144458, Exp. Sep. 2026 Lot#: 24143994, Exp. Sep. 2026 Lot#: 24142987, Exp. July 2026 Lot#: 24143316, Exp. July 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Lowellville", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97653", "recalling_firm": "RC Outsourcing, LLC", "address_1": "102 E Water St", "address_2": "", "postal_code": "44436-1117", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0003-2026", "product_description": "Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.", "product_quantity": "2,669 syringes", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20250922", "center_classification_date": "20251006", "report_date": "20251015", "code_info": "Lot #  20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211623"], "brand_name": ["CARBAMAZEPINE"], "generic_name": ["CARBAMAZEPINE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-583", "60687-594"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARBAMAZEPINE"], "rxcui": ["402505", "402506"], "spl_id": ["33789d2e-f734-3430-e063-6294a90a71d6"], "spl_set_id": ["7108d630-89bc-4815-b6fb-a1f4676c496e"], "package_ndc": ["60687-583-11", "60687-583-21", "60687-594-11", "60687-594-21"], "original_packager_product_ndc": ["16571-681", "16571-682"], "nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "unii": ["33CM23913M"]}, "product_type": "Drugs", "event_id": "97634", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0675-2025", "product_description": "Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217.  Carton NDC 60687-594-21; (Individual Dose NDC: 60687-594-11)", "product_quantity": "360 cartons", "reason_for_recall": "Failed Dissolution Specifications.", "recall_initiation_date": "20250915", "center_classification_date": "20250929", "report_date": "20251008", "code_info": "Lot #: 1024078, Exp. Date 08/31/2026"}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209288"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-511", "67877-512", "67877-513", "67877-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["777b866a-796a-4d15-8cb6-dd0c9a1856e2"], "spl_set_id": ["67e60880-091a-4df7-8696-6e6c42a490e2"], "package_ndc": ["67877-511-90", "67877-511-05", "67877-511-10", "67877-511-55", "67877-511-33", "67877-511-38", "67877-512-90", "67877-512-05", "67877-512-10", "67877-512-44", "67877-512-33", "67877-512-38", "67877-513-90", "67877-513-05", "67877-513-10", "67877-513-23", "67877-513-33", "67877-513-38", "67877-514-90", "67877-514-05", "67877-514-10", "67877-514-33", "67877-514-38"], "is_original_packager": [true], "upc": ["0367877512051", "0367877513102", "0367877514109"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "97639", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0018-2026", "product_description": "Atorvastatin Calcium Tablets USP, 40 mg, Rx Only,  a). 90-count (NDC 67877-513-90), b).  500-count (NDC 67877-513-05), c). 1000-count (NDC 67877-513-10),  Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.", "product_quantity": "", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250919", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot#: 25140933, Exp. Feb. 2027 Lot#: 25140477, Exp.  Dec. 2026 Lot#: 24144254, Exp. Oct. 2026 Lot#: 24144163, Exp.  Sep. 2026 Lot#: 24143995, Exp.  Sep. 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97779", "recalling_firm": "STAQ Pharma, Inc.", "address_1": "14135 E 42nd Ave Ste 50", "address_2": "", "postal_code": "80239-5214", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0023-2026", "product_description": "Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.", "product_quantity": "", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20251009", "center_classification_date": "20251015", "report_date": "20251022", "code_info": "Lot #: 25104595A, Expiry: 27DEC2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97779", "recalling_firm": "STAQ Pharma, Inc.", "address_1": "14135 E 42nd Ave Ste 50", "address_2": "", "postal_code": "80239-5214", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0025-2026", "product_description": "FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.", "product_quantity": "", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20251009", "center_classification_date": "20251015", "report_date": "20251022", "code_info": "Lot: 25102464B, Expiry: 26NOV2025; 25102370A, Expiry: 20OCT2025; 25102369A, Expiry: 19OCT2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "New Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA761234"], "brand_name": ["OPDUALAG"], "generic_name": ["NIVOLUMAB AND RELATLIMAB-RMBW"], "manufacturer_name": ["E.R. Squibb & Sons, L.L.C."], "product_ndc": ["0003-7125"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NIVOLUMAB", "RELATLIMAB"], "rxcui": ["2596778", "2596784"], "spl_id": ["1150d07b-4d33-4285-a242-1ecf12ed5a4c"], "spl_set_id": ["b22c9d83-3256-4e17-85f7-f331a504adc6"], "package_ndc": ["0003-7125-11"], "is_original_packager": [true], "nui": ["N0000191260", "N0000191259", "N0000194003", "N0000194002"], "pharm_class_epc": ["Programmed Death Receptor-1 Blocking Antibody [EPC]", "Lymphocyte Activation Gene-3 Blocker [EPC]"], "pharm_class_moa": ["Programmed Death Receptor-1-directed Antibody Interactions [MoA]", "Lymphocyte Activation Gene-3 Antagonists [MoA]"], "unii": ["31YO63LBSN", "AF75XOF6W3"]}, "product_type": "Drugs", "event_id": "97839", "recalling_firm": "Bristol-Myers Squibb Company", "address_1": "1 Squibb Dr", "address_2": "", "postal_code": "08901-1588", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0097-2026", "product_description": "Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11", "product_quantity": "12,778 total vials", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20251021", "center_classification_date": "20251023", "report_date": "20251029", "code_info": "Lot: 033A23B, Expiry: 4/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0665-2025", "product_description": "Torrey Pines Dermatology & Laser Center Benzaderm BPO Cleanser 10% (Benzoyl Peroxide 10%) 7oz (201 g), Torreypines.com", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97613", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0006-2026", "product_description": "Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.", "product_quantity": "54,432 bottles", "reason_for_recall": "Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.", "recall_initiation_date": "20250916", "center_classification_date": "20251006", "report_date": "20251015", "code_info": "Lot # D2300045, Exp 12/31/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210698"], "brand_name": ["SUCCINYLCHOLINE"], "generic_name": ["SUCCINYLCHOLINE"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc.,"], "product_ndc": ["43598-666"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["SUCCINYLCHOLINE CHLORIDE"], "rxcui": ["1594589"], "spl_id": ["3e170b7b-58cc-fd7e-a547-7feaae62194a"], "spl_set_id": ["f55dd1c0-c259-219a-5bca-f139e9515d07"], "package_ndc": ["43598-666-11", "43598-666-25"], "is_original_packager": [true], "upc": ["0343598666259", "0343598666112"], "unii": ["I9L0DDD30I"]}, "product_type": "Drugs", "event_id": "97690", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "600 College Rd E Ste 4000", "address_2": "", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA.", "recall_number": "D-0008-2026", "product_description": "Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540.  NDC: 43598-666-25", "product_quantity": "571 vials", "reason_for_recall": "Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.", "recall_initiation_date": "20250926", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lot # K250048", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091346"], "brand_name": ["VIORELE"], "generic_name": ["DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-318"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["248310", "249357", "748797", "759743", "1252016"], "spl_id": ["34bbda2e-5e46-488d-9b7d-09081112ceaa"], "spl_set_id": ["39988aa6-8f68-40e8-9bdd-c40a3bdaad61"], "package_ndc": ["68462-318-29"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "97547", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0021-2026", "product_description": "Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3 Blisters each containing 28 Tablets, Rx only, 28 day Regimen, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA., Mahwah, NJ, 07430, NDC 68462-318-29.", "product_quantity": "26,928 packs", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250903", "center_classification_date": "20251015", "report_date": "20251022", "code_info": "Batch number 20230733, Exp Date: October 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0673-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 30 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-034-01", "product_quantity": "11,928 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot#: GPC250181A, Exp Date: 06-19-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Yangzhou", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97278", "recalling_firm": "YANGZHOU YULOU PAPER PRODUCTS CO., LTD", "address_1": "No. 888 Jinbao West Road", "address_2": "Baoying County", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "N/A", "recall_number": "D-0659-2025", "product_description": "Quick Touch Alcohol Prep Pads(Isopropyl Alcohol 70%), 100 Sterile Pads per carton, AUM Pharmaceuticals, 320 Oser Ave., Hauppauge, NY 11788.", "product_quantity": "500 cases", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20250721", "center_classification_date": "20250923", "report_date": "20251001", "code_info": "Lot #: 20240610, Exp. Date 06/2029", "more_code_info": ""}, {"status": "Ongoing", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA207934"], "brand_name": ["EVEROLIMUS"], "generic_name": ["EVEROLIMUS"], "manufacturer_name": ["ENDO USA, Inc."], "product_ndc": ["49884-119", "49884-125", "49884-127", "49884-128"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EVEROLIMUS"], "rxcui": ["845507", "845515", "998189", "1119400"], "spl_id": ["d82ae1c1-347f-44cb-a0bd-56d0fe4d267f"], "spl_set_id": ["45d54974-3fc4-4237-a2fa-3158ca1a8105"], "package_ndc": ["49884-119-52", "49884-119-91", "49884-125-52", "49884-125-91", "49884-127-52", "49884-127-91", "49884-128-52", "49884-128-91"], "is_original_packager": [true], "nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "unii": ["9HW64Q8G6G"]}, "product_type": "Drugs", "event_id": "97557", "recalling_firm": "Endo USA, Inc.", "address_1": "9 Great Valley Pkwy", "address_2": "", "postal_code": "19355-1304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0026-2026", "product_description": "Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91", "product_quantity": "1,041 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.", "recall_initiation_date": "20250905", "center_classification_date": "20251016", "report_date": "20251022", "code_info": "Lot #: 550172301, Exp. Date January 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Prescott", "state": "WI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97652", "recalling_firm": "SV Labs Prescott Corporation", "address_1": "1115 Dexter St N", "address_2": "", "postal_code": "54021-1768", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0022-2026", "product_description": "Aloe Up Sport Performance Sunscreen Lotion SPF 30, 1 FL OZ (30 mL) per tube, Mfd. for: ALOE UP, 9700 W. 76th St., Ste 112, Eden Prairie, Minnesota 55344", "product_quantity": "11,386 tubes", "reason_for_recall": "cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.", "recall_initiation_date": "20250925", "center_classification_date": "20251015", "report_date": "20251022", "code_info": "Lot#: 25196, Exp 2/16/2026", "more_code_info": ""}]